Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
Blood ; 116(25): 5752-61, 2010 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-20858856

RESUMEN

The membrane-type matrix metalloproteinases (MT-MMPs) are essential for pericellular matrix remodeling in late stages of development, as well as in growth and tissue homeostasis in postnatal life. Although early morphogenesis is perceived to involve substantial tissue remodeling, the roles of MT-MMPs in these processes are only partially characterized. Here we explore the functions of 2 prominently expressed MT-MMPs, MT1-MMP and MT2-MMP, and describe their roles in the process of placental morphogenesis. The fetal portion of the placenta, in particular the labyrinth (LA), displays strong overlapping expression of MT1-MMP and MT2-MMP, which is critical for syncytiotrophoblast formation and in turn for fetal vessels. Disruption of trophoblast syncytium formation consequently leads to developmental arrest with only a few poorly branched fetal vessels entering the LA causing embryonic death at embryonic day 11.5. Through knockdown of MMP expression, we demonstrate that either MT1-MMP or MT2-MMP is crucial specifically during development of the LA. In contrast, knockdown of MT-MMP activity after LA formation is compatible with development to term and postnatal life. Taken together these data identify essential but interchangeable roles for MT1-MMP or MT2-MMP in placental vasculogenesis and provide the first example of selective temporal and spatial MMP activity required for development of the mouse embryo.


Asunto(s)
Oído Interno/embriología , Oído Interno/patología , Metaloproteinasa 14 de la Matriz/metabolismo , Metaloproteinasa 15 de la Matriz/metabolismo , Placenta/embriología , Placenta/patología , Animales , Western Blotting , Oído Interno/metabolismo , Matriz Extracelular/metabolismo , Femenino , Técnica del Anticuerpo Fluorescente , Técnicas para Inmunoenzimas , Metaloproteinasa 14 de la Matriz/genética , Metaloproteinasa 15 de la Matriz/genética , Ratones , Placenta/metabolismo , Embarazo , Preñez
2.
Oncol Rep ; 14(3): 713-7, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16077980

RESUMEN

Vimentin is a member of the intermediate filament family, and the NF-kappaB binding site is located in the human vimentin promoter. To gain insight into the role of NF-kappaB in the regulation of the vimentin gene during 12-O-tetradecanoylphorbol-13-acetate (TPA)-dependent differentiation of HL-60 cells, the effect of pyrrolidine dithiocarbamete (PDTC) has been investigated using Northern blot hybridization and DNA mobility shift assay. PDTC inhibited macrophage-like morphologic change of HL-60 cells by TPA. TPA-dependent increase of vimentin mRNA level was decreased in a time- and dose-dependent manner by pretreatment with PDTC. One DNA-protein complex was formed by DNA mobility shift assay when the NF-kappaB or AP-1 binding sites were incubated with nuclear extract prepared from TPA-treated HL-60 cells, but no protein bound in control HL-60 cells without TPA. After PDTC pretreatment, NF-kappaB binding activity vanished but AP-1 binding activity was unchanged. Taken together, these results suggest that NF-kappaB may be an essential transacting factor for transcriptional repression of the vimentin gene by PDTC during TPA-dependent differentiation of HL-60 cells.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Pirrolidinas/farmacología , Acetato de Tetradecanoilforbol/farmacología , Tiocarbamatos/farmacología , Vimentina/genética , Northern Blotting , Diferenciación Celular/genética , Forma de la Célula/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayo de Cambio de Movilidad Electroforética , Células HL-60 , Humanos , Microscopía de Contraste de Fase , FN-kappa B/metabolismo , Unión Proteica/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Factores de Tiempo , Transcripción Genética/efectos de los fármacos
3.
Oncol Rep ; 14(3): 727-31, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16077983

RESUMEN

To gain insight on the role of transacting factors in the regulatory mechanism of H2B histone gene expression during the differentiation of HL-60 cells by 12-O-tetradecanoylphorbol 13-acetate (TPA), the binding pattern of nuclear proteins to various elements in the human H2B histone gene upstream region have been investigated with DNase I footprinting and DNA mobility shift assay. The level of H2B histone mRNA rapidly reduced at 24 h in TPA-treated HL-60 cells. The H2B histone mRNA was repressed in proportion to the concentration of TPA. In DNase I footprinting analysis, one nuclear factor (octamer-binding transcription factor, OTF) bound at -42 bp (octamer motif), before and after TPA-induced differentiation of HL-60 cells. One DNA-protein complex (OTF) was formed by DNA mobility shift assay when octamer element was incubated with nuclear extract of undifferentiated HL-60 cells. In DNA mobilith shift assay, OTF vanished, and phosphorylated OTF (p-OTF) newly appeared during TPA-induced differentiation. p-OTF was not detected after pretreatment of the protein kinase C inhibitor, staurosporin, but was not changed after CHX treatment. TPA-induced repression of H2B histone mRNA was also restored after pretreatment of staurosporin. These results suggest that OTF is phosphorylated by protein kinase C during TPA-induced differentiation of HL-60 and the transcriptional repression of the H2B histone gene may be mediated by protein kinase C-dependent phosphorylation of OTF.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Histonas/genética , Ésteres del Forbol/farmacología , Factores de Transcripción/metabolismo , Secuencia de Bases , Sitios de Unión/genética , Northern Blotting , Diferenciación Celular/genética , Relación Dosis-Respuesta a Droga , Ensayo de Cambio de Movilidad Electroforética , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Células HL-60 , Humanos , Proteínas Nucleares/metabolismo , Oligonucleótidos/genética , Oligonucleótidos/metabolismo , Fosforilación/efectos de los fármacos , Regiones Promotoras Genéticas/genética , Unión Proteica/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo
4.
Cancer Lett ; 184(1): 81-8, 2002 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-12104051

RESUMEN

DNA topoisomerase IIalpha (Topo IIalpha) is regulated in late S phase-dependent manner. To identify late S phase-dependent cis-acting elements of Topo IIalpha gene, we have investigated the synchronized HeLa cells with chloramphenicol acetyltransferase and DNase I footprinting assays. The level of Topo IIalpha mRNA increased after release from aphidicolin block and reached a maximum in 8h (late S phase) in HeLa cells, and Topo II unknotting activity was also in parallel with the level of Topo IIalpha mRNA. The late S phase-regulatory element was found to be located in the region containing ATF-binding element between -290 and -90bp and the region was required for a maximal stimulation during late S phase. DNase I footprinting assay showed that ATF-binding element and novel cis-acting element (Topo IIalpha-specific sequence) were the principal protein-binding sites and the proteins interacting with these elements were induced during late S phase. One DNA-protein complex was formed by DNA mobility shift assay when ATF-binding site was incubated with nuclear extract prepared from late S phase cells, but no protein bound in non-S phase cells. Taken together, these results suggest that ATF may be essential transacting factor for maximal expression of Topo IIalpha gene during late S phase in HeLa cells.


Asunto(s)
Proteínas Sanguíneas/metabolismo , ADN-Topoisomerasas de Tipo II/genética , Proteínas de Neoplasias/metabolismo , Fase S/genética , Factores de Transcripción/metabolismo , Transcripción Genética , Factores de Transcripción Activadores , Antígenos de Neoplasias , Secuencia de Bases , Proteínas Sanguíneas/genética , Northern Blotting , Ciclo Celular/genética , Cloranfenicol O-Acetiltransferasa/metabolismo , Huella de ADN , ADN-Topoisomerasas de Tipo II/metabolismo , Proteínas de Unión al ADN , Desoxirribonucleasa I/metabolismo , Ensayo de Cambio de Movilidad Electroforética , Regulación Enzimológica de la Expresión Génica , Genes Reguladores/genética , Células HeLa/metabolismo , Humanos , Datos de Secuencia Molecular , Proteínas de Neoplasias/genética , Regiones Promotoras Genéticas , ARN Mensajero , Factores de Transcripción/genética , Activación Transcripcional
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA